Nie jesteś zalogowany na forum.
Strony: 1
The earliest such proof comes from the primary research of radiolabeled anti-CD20 therapy. Topics had been preloaded with chilly (unradiolabeled) antibody to enhance biodistribution of the radio-labeled antibody. Unexpectedly, some topics demonstrated shrinkage of lymphoma after the chilly antibody however earlier than the radiolabeled antibody was given(18). The chilly antibody used on this research was a murine IgG2a (B1), demonstrating that even a murine IgG antibody, with its comparatively poor potential to work together with human Fc receptors, can have anti-tumor exercise. Rituximab injected immediately into the cerebrospinal fluid in patients with central nervous system lymphoma has been reported to have native anti-lymphoma results(19). The lack of serious ranges of complement or cells able to mediating ADCC within the CNS would counsel a direct impact of rituximab on the malignant cells. Then again, a small research suggests the therapeutic impact of CNS administration of rituximab might be augmented by concomitant injection of serum into the CNS as a supply of complement(20). The general idea that rituximab will improve the efficacy of chemotherapy could seem counter-intuitive if one assumes that the mechanism of motion of monoclonal antibody therapy is predicated on activation of immune effector mechanisms.
Also visit my web blog ... rituximab side effects mayo clinic (privacy)
my homepage :: rituximab fda label (click the up coming webpage)
Offline
Strony: 1